Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

v3.23.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Common Stock [Member]
Common Stock Issuable [Member]
Additional Paid-in Capital [Member]
Subscription Receivable [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock, Common [Member]
Total
Beginning balance, value at Jun. 30, 2021 $ 5,000 $ 14,056 $ 54,074,110 $ (58,199,466) $ 1,085,204 $ (46,477) $ (3,067,573)
Beginning balance, shares at Jun. 30, 2021 500,000 1 14,055,393 59            
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest $ 9,445 190,741 200,186
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest, shares     9,445,009              
Issuance of common stock for services and accrued expenses $ 17,934 563,927 581,861
Issuance of common stock for services and accrued expenses, shares     17,934,379              
Issuance of common stock for exercise of warrants $ 7 $ 2 374,991 (100,000) 275,000
Issuance of common stock for exercise of warrants, shares     6,875 2,500            
Issuance of common stock for alternate cashless exercise of warrants $ 2,400 $ 2,000 (4,400)
Issuance of common stock for alternate cashless exercise of warrants, shares     2,399,988 1,999,990            
Reclassification of put premium upon debt conversion 109,643 109,643
Stock based compensation in connection with stock option grants 20,718 20,718
Foreign currency translation loss 64,193 64,193
Deemed dividend upon alternate cashless exercise of warrants 114,844 (114,844)
Net loss (490,658) (490,658)
Ending balance, shares at Sep. 30, 2021 500,000 1 43,841,644 2,002,549            
Ending balance, value at Sep. 30, 2021 $ 5,000 $ 43,842 $ 2,002 55,444,574 (100,000) (58,804,968) 1,149,397 (46,477) (2,306,630)
Beginning balance, value at Jun. 30, 2021 $ 5,000 $ 14,056 54,074,110 (58,199,466) 1,085,204 (46,477) (3,067,573)
Beginning balance, shares at Jun. 30, 2021 500,000 1 14,055,393 59            
Foreign currency translation loss                   1,400
Net loss                   (1,753,322)
Reclassification of put premium upon debt conversion                   227,150
Ending balance, shares at Mar. 31, 2022 500,000   85,030,026 1,149,635            
Ending balance, value at Mar. 31, 2022 $ 5,000 $ 85,030 $ 1,149 56,319,693 (60,398,419) 1,086,604 (46,477) (2,947,420)
Beginning balance, value at Sep. 30, 2021 $ 5,000 $ 43,842 $ 2,002 55,444,574 (100,000) (58,804,968) 1,149,397 (46,477) (2,306,630)
Beginning balance, shares at Sep. 30, 2021 500,000 1 43,841,644 2,002,549            
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest $ 1,818 24,908 26,726
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest, shares       1,818,097            
Issuance of common stock for exercise of warrants $ 2 $ (2) 100,000 100,000
Issuance of common stock for exercise of warrants, shares     2,500 (2,500)            
Issuance of common stock for alternate cashless exercise of warrants $ 6,400 $ (2,000) (4,400)
Issuance of common stock for alternate cashless exercise of warrants, shares       (1,999,990)            
Stock based compensation in connection with stock option grants 20,718 20,718
Foreign currency translation loss (7,697) (7,697)
Deemed dividend upon alternate cashless exercise of warrants 93,398 (93,398)
Net loss (799,977) (799,977)
Issuance of common stock for deferred offering cost 1,000 19,000 20,000
Issuance of common stock for deferred offering cost, shares     $ 1,000,000              
Issuance of common stock for alternate cashless exercise of warrants, shares     6,399,968              
Reclassification of put premium upon debt conversion 16,667 16,667
Ending balance, shares at Dec. 31, 2021   1 53,062,209 59            
Ending balance, value at Dec. 31, 2021 5,000 $ 53,062 55,614,865 (59,698,343) 1,141,700 (46,477) (2,930,193)
Issuance of common stock for exercise of warrants $ 1 $ 1 99,998 100,000
Issuance of common stock for exercise of warrants, shares     1,250 1,250            
Issuance of common stock for alternate cashless exercise of warrants $ 9,800 (9,800)
Issuance of common stock for alternate cashless exercise of warrants, shares     9,799,951              
Foreign currency translation loss (55,096) (55,096)
Deemed dividend upon alternate cashless exercise of warrants 237,389 (237,389)
Net loss (462,687) (462,687)
Reclassification of put premium upon debt conversion 100,840 100,840
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest   $ 19,226 170,742 189,968
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest, shares       19,225,725            
Issuance of common stock for services $ 2,941 $ 1,148 84,941 89,030
Issuance of common stock for services, shares     2,940,891 1,148,326            
Stock based compensation in connection with stock warrant grant 20,718 20,718
Ending balance, shares at Mar. 31, 2022 500,000   85,030,026 1,149,635            
Ending balance, value at Mar. 31, 2022 $ 5,000 $ 85,030 $ 1,149 56,319,693 (60,398,419) 1,086,604 (46,477) (2,947,420)
Beginning balance, value at Jun. 30, 2022 $ 5,000 $ 220,351 $ 19,597 57,124,982 (23,758) (61,557,893) 1,234,549 (46,477) (3,023,649)
Beginning balance, shares at Jun. 30, 2022 500,000 1 220,350,921 19,597,024            
Issuance of common stock for exercise of warrants $ 1 $ 1 99,998 100,000
Issuance of common stock for exercise of warrants, shares     1,250 1,250            
Issuance of common stock for alternate cashless exercise of warrants $ 158,399 (158,399)
Issuance of common stock for alternate cashless exercise of warrants, shares     158,399,208              
Foreign currency translation loss 126,396 126,396
Deemed dividend upon alternate cashless exercise of warrants 389,235 (389,235)
Net loss (617,295) (617,295)
Reclassification of put premium upon debt conversion 133,646 133,646
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest $ 264,493 192,446 456,939
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest, shares     264,492,661              
Stock based compensation in connection with stock warrant grant 2,408 2,408
Issuance of common stock for cash $ 14,337 10,374 23,758 48,469
Issuance of common stock for cash, shares     14,336,712              
Issuance of common stock for issuable shares, shares $ 19,597 $ (19,597)
Issuance of common stock for issuable shares, shares     19,596,965 (19,596,965)            
Warrant grant for settlement of accounts payable 5,551 5,551
Ending balance, shares at Sep. 30, 2022 500,000 1 677,177,717 1,309            
Ending balance, value at Sep. 30, 2022 $ 5,000 $ 677,178 $ 1 57,800,241 (62,564,423) 1,360,945 (46,477) (2,767,535)
Beginning balance, value at Jun. 30, 2022 $ 5,000 $ 220,351 $ 19,597 57,124,982 (23,758) (61,557,893) 1,234,549 (46,477) (3,023,649)
Beginning balance, shares at Jun. 30, 2022 500,000 1 220,350,921 19,597,024            
Foreign currency translation loss                   59,198
Net loss                   (1,912,522)
Reclassification of put premium upon debt conversion                   351,992
Ending balance, shares at Mar. 31, 2023 1 2,621,297,786 4,434            
Ending balance, value at Mar. 31, 2023 $ 2,621,298 $ 4 57,068,986 (63,878,972) 1,293,747 (46,477) (2,941,414)
Beginning balance, value at Sep. 30, 2022 $ 5,000 $ 677,178 $ 1 57,800,241 (62,564,423) 1,360,945 (46,477) (2,767,535)
Beginning balance, shares at Sep. 30, 2022 500,000 1 677,177,717 1,309            
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest $ 380,506 (214,815) 165,691
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest, shares     380,506,070              
Issuance of common stock for exercise of warrants $ 3 99,997 100,000
Issuance of common stock for exercise of warrants, shares     2,500              
Issuance of common stock for alternate cashless exercise of warrants $ 33,600 (33,600)
Issuance of common stock for alternate cashless exercise of warrants, shares     33,599,832              
Foreign currency translation loss (107,812) (107,812)
Deemed dividend upon alternate cashless exercise of warrants 19,322 (19,322)
Net loss (485,418) (485,418)
Reclassification of put premium upon debt conversion 85,346 85,346
Issuance of common stock for services $ 79,412 (22,601) 56,811
Issuance of common stock for services, shares     79,412,132              
Issuance of common stock for issuable shares, shares     $ 1,250 (1,250)            
Issuance of common stock for issuable shares 1 (1)
Issuance of common stock in connection with a note payable $ 75,000 (37,500) 37,500
Issuance of common stock in connection with a note payable, shares     75,000,000              
Ending balance, shares at Dec. 31, 2022 500,000 1 1,245,699,501 59            
Ending balance, value at Dec. 31, 2022 $ 5,000 $ 1,245,700 57,696,390 (63,069,163) 1,253,133 (46,477) (2,915,417)
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest   $ 1,375,598 (940,400) 435,198
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest, shares       1,375,598,285            
Issuance of common stock for exercise of warrants   $ 4 174,996 175,000
Issuance of common stock for exercise of warrants, shares     3,750 4,375            
Foreign currency translation loss 40,614 40,614
Net loss (809,809) (809,809)
Reclassification of put premium upon debt conversion 133,000 133,000
Retirement of Series A Preferred Stock (5,000) 5,000
Retirement of Series A Preferred Stock, shares $ (500,000)                  
Ending balance, shares at Mar. 31, 2023 1 2,621,297,786 4,434            
Ending balance, value at Mar. 31, 2023 $ 2,621,298 $ 4 $ 57,068,986 $ (63,878,972) $ 1,293,747 $ (46,477) $ (2,941,414)